Skip to main content
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.190
-0.090 (-3.95%)
At close: Nov 13, 2026, 4:00 PM EST
2.180
-0.010 (-0.45%)
After-hours: Nov 13, 2026, 7:30 PM EST

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9580273875281
Market Cap Growth
82.20%202.37%-30.71%-48.99%-73.29%328.57%
Enterprise Value
6983313957243
Last Close Price
2.192.712.204.6011.1047.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
27.9265.49----
PB Ratio
--5.03-1.14-3.2610.1313.51
P/TBV Ratio
----10.1313.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
20.3068.00----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.91-0.04-0.27-0.781.420.03
Net Debt / Equity Ratio
152.070.45-0.21-0.39-1.29-1.30
Net Debt / EBITDA Ratio
1.310.45-0.24-0.170.220.29
Net Debt / FCF Ratio
1.250.51-0.45-0.210.240.72
Asset Turnover
0.170.15----
Quick Ratio
0.790.280.070.241.292.32
Current Ratio
0.860.310.150.361.662.74
Return on Equity (ROE)
-----281.79%-
Return on Assets (ROA)
-63.99%-121.85%-224.60%-104.08%-94.66%-330.91%
Return on Capital Employed (ROCE)
-6980.40%103.60%108.20%235.10%-433.30%-453.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-35.41%-35.68%-94.69%-78.73%-52.95%-33.11%
FCF Yield
-21.82%-17.59%-40.09%-56.56%-52.96%-13.41%
Buyback Yield / Dilution
-110.42%-101.06%-40.50%-15.20%-40.17%-36.90%
SEC Filings: 10-K · 10-Q